tm logo
Trademark Search
AMTAGVI

View On IC.GC.CA

AMTAGVI
REGISTERED

on 05 Jul 2023

Last Applicant/ Owned by

IOVANCE BIOTHERAPEUTICS GMBH

c/o Bratschi AG,Zweigniederlassung Zug,Gubelstrasse 11CH-6300 Zug

CH

Serial Number

2071628 filed on 21st Oct 2020

Registration Number

TMA1188226 registered on 05th Jul 2023

Registration expiry Date

21st Oct 2030

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

AMTAGVI

Trademark usage description

pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceutic Read More

Classification Information

Class [005]
Pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceutical preparations and biological preparations for the treatment of cancer, immune system related and oncological diseases and disorders; pharmaceutical products and biological preparations for medical diagnostics in the fields of cancer, oncology, and immune system diseases and disorders.

Classification kind code

11

Class [044]
Medical services, namely, cell modification for treatment of cancer, oncological diseases and disorders, immune system diseases and disorders; immunotherapy treatments; medical diagnosis and treatment services, namely, medical analysis services for cancer diagnosis and prognosis, medical analysis services for the diagnosis and prognosis of oncological and immune system diseases and disorders, medical diagnosis and treatment services in the fields of cancer, oncology and immune system diseases and disorders; provision of information on oncology and immunotherapy treatments; providing medical information and consultancy services relating to diagnosis and treatment for cancer, oncological diseases and disorders, and immune system diseases and disorders, and relating to immunotherapy treatments, tumor infiltrating lymphocyte (TIL) therapies, T-cell-based immunotherapy and peripheral blood lymphocyte (PBL) therapies; providing pharmaceutical information; providing medical information in the field of isolation, collection, and banking of human biological tissue for immunotherapy; collection and preservation of biological tissues for diagnostic or treatment purposes in the fields of cancer, oncology and immune system diseases and disorders.

Classification kind code

11

Mark Details

Serial Number

2071628

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 04th Aug 2022		Agent Changed
Submitted for opposition 22
on 08th Apr 2022		Search Recorded
Submitted for opposition 20
on 08th Apr 2022		Examiner's First Report
Submitted for opposition 223
on 08th Apr 2022		Total Provisional Refusal
Submitted for opposition 256
on 18th Oct 2021		Notification of Possible Opposition Sent
Submitted for opposition 257
on 17th Dec 2020		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 16th Dec 2020		Formalized
Submitted for opposition 1
on 16th Dec 2020		Created
Submitted for opposition 228
on 21st Oct 2020		International Registration
Submitted for opposition 30
on 21st Oct 2020		Filed